Asia Pacific Lancet and Pen Needles Market Research Report Information by Type (lancets and pen needles), Application (Insulin, Capillary Blood Sampling, Hormones, Glucose Like Peptide (GLP), Skin Testing, and Others), End Use (Hospitals & Clinics, Diagnostic Centers & Medical Institutions, Home Care & Home Diagnostics, Research & Academic Laboratories, and Others), by Region (China, India Japan, South Korea, Australia, and Rest of the Asia-Pacific) Industry Forecast to 2032 Market Overview It is anticipated that the Asia Pacific Lancet and Pen Needles Market will experience a robust market expansion with a compound annual growth rate (CAGR) of 11.13% during the review period. Lancets are single-use devices that are employed by healthcare professionals for the purpose of conducting narrow blood tests. Lancets are an indispensable component of the sharp-injury aversion programs implemented in hospitals, clinics, research centers, and physicians' offices. Lancets are a commonly employed alternative device for the collection of blood samples. Pen needles and lancets are gaining global recognition and acceptability because of their numerous convenient features, which provide them with an advantage over traditional vein puncture methods. A pen needle is a hollow needle that is affixed to injection pens and is embedded in a plastic core. Pen needles are employed in conjunction with injection pens to administer injectable medications into the body. The Asia-Pacific lancet and pen needles market is being driven by the primary factors of the growing incidences of diabetes in the region and the strategic initiatives associated with pen needles by market players. Nevertheless, the Asia-Pacific market is anticipated to experience growth constraints due to the emergence of alternative drug delivery technologies. However, the market is expected to generate profitable opportunities due to the expanding geriatric population in the Asia-Pacific region. Market Segmentation The Asia-Pacific lancet and pen needles market has been segmented into lancets and pen needles based on type. The lancet and pen needles market has been segmented into insulin, capillary blood sampling, hormones, glucose-like peptide (GLP), skin testing, and other applications, as determined by their application. The lancet and pen needles market are segmented by end user, including hospitals and clinics, diagnostic centers and medical institutions, home care and home diagnostics, research and academic laboratories, and others. The Asia-Pacific lancet and pen needle market has been segmented into China and India based on country. Australia, Japan, South Korea, and the remainder of the Asia-Pacific region. In 2022, China held the greatest market share. Nevertheless, India is anticipated to experience the most rapid rate of growth during the forecast period. Major Players Novo Nordisk A/S, Terumo Corporation, B. Braun SE, Nipro Corporation, Abbott, and Cardinal Health are the main market players.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook